Showing results (261-270 of 554) with videos related to

Sort By:
Pageof 56
The Oncologist|November 11, 2023
A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab/Ipilimumab After Nivolumab in Renal Cell CarcinomaRana R McKay, Katharina Leucht, Wanling Xie, et al.
Alcoholism, Clinical and Experimental Research|October 6, 1997
Ethanol-induced changes in prostaglandin E concentration in the intact cerebral cortex of preterm and near-term fetal sheepJ D Reynolds, D H Penning, K A Kimura, et al.
Nuclear Medicine Communications|October 1, 1996
Frequency of extra-cardiac activity and its effect on 99Tcm-MIBI cardiac SPET interpretationP K Rehm, F B Atkins, H A Ziessman, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 21, 2007
Preserved expression of GLUT4 prevents enhanced agonist-induced vascular reactivity and MYPT1 phosphorylation in hypertensive mouse aortaKevin B Atkins, Antoine Prezkop, James L Park, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 18, 2014
Report of a phase I evaluation of dose and schedule of interleukin-1 alpha and cyclophosphamide in patients with advanced tumors: An Eastern Cooperative Oncology Group study (PX990) and review of IL-1-based studies of hematopoietic reconstitutionJanice P Dutcher, Donna Neuberg, Michael B Atkins, et al.
Journal for Immunotherapy of Cancer|September 25, 2019
High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014Janice P Dutcher, Douglas J Schwartzentruber, Howard L Kaufman, et al.
British Journal of Psychology (London, England : 1953)|August 11, 2018
Does your mindfulness benefit others? A systematic review and meta-analysis of the link between mindfulness and prosocial behaviourJames N Donald, Baljinder K Sahdra, Brooke Van Zanden, et al.
Medical Oncology (Northwood, London, England)|November 20, 1998
Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferonR K Alpaugh, M von Mehren, I Palazzo, et al.
Cancers|December 10, 2021
Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer AnalysisDongyu Zhang, Neil J Shah, Michael Cook, et al.
Cancer|September 4, 2009
Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanomaJohn Glaspy, Michael B Atkins, Jon M Richards, et al.
Pageof 56